Slow but definite progress has been made in recognizing the differences in disease biology,
host factors, and psychosocial issues related to management of hematologic malignancies …

A significant increase in infections caused by multidrug-resistant organisms (MDRO) has
been observed in recent years, resulting in an increase of mortality in all fields of health …

Opinion statement Successful management of adolescent and young adult patients with
Hodgkin lymphoma (HL) requires a multidisciplinary approach to care with special attention …

Background Adolescent and young adults (AYA) represent one third of patients affected by
Hodgkin lymphoma (HL). These patients are frequently treated either with pediatric or adult …

Objectives: This study investigated the possible prognostic factors for the long-term survival
(Cure Rate) of Hodgkin Lymphoma patients who underwent HSCT. Methods: This …

Background: Autologous hematopoietic stem cell transplants (HSCT) is the standard of care
for transplant-eligible patients with newly diagnosed multiple myeloma (MM) and patients …

Pediatric, adolescent, and young adult patients with relapsed or refractory Hodgkin
lymphoma receive multimodal therapy, including autologous hematopoietic cell …

Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) provides durable remission
for patients with adult T‐cell leukemia/lymphoma (ATL); however, few studies have focused …

Patients with primary refractory Hodgkin lymphoma (ref-HL) can still be salvaged with high-
dose chemotherapy (HDC) and autologous stem cell transplantation (auto-SCT). Outcomes …

Strategies used for the treatment of children with Hodgkin lymphoma (HL) over the last four
decades have resulted in excellent long-term survivals. However, the short-and long-term …